Key result
Triazolam use in a 52-year-old obese woman was associated with the development of severe non-cardiac pulmonary edema requiring non-invasive ventilation.
Case Report (n=1)
Triazolam may cause severe non-cardiac pulmonary edema requiring non-invasive ventilation, and should be used with caution in obese patients.
Answers are grounded in this paper and cite their sources.
Triazolam may be linked to non-cardiogenic edema in obesity; single case leaves causality unconfirmed.
Triazolam belongs to the group of benzodiazepines and may have side effects on the respiratory system which include not only respiratory depression, but also transient benign non cardiac pulmonary edema. A 52 year old obese woman developed pulmonary edema after she was taking triazolam for almost two weeks without any other medications. All possible cardiogenic and non cardiogenic causes were excluded. The condition was severe enough to require non invasive ventilation. This case differs from the other report of triazolam associated non cardiac pulmonary edema for its severity requiring non invasive ventilation. The pathogenetic mechanism is unknown. Despite the lack of objective evidence to explain pulmonary venous hypertensive changes in our case, we want to advice that triazolam should be used with caution in obese patients, as obesity might aggravate this described drug adverse reaction.
No takes yet. Share an insight, caveat, or question.
Stefano et al. (2012) conducted a case report in Non cardiac pulmonary edema (n=1). Triazolam was evaluated on Development of non cardiac pulmonary edema. Triazolam use in a 52-year-old obese woman was associated with the development of severe non-cardiac pulmonary edema requiring non-invasive ventilation.
Synapse has enriched 10 related papers. Consider them for comparative context: